Enhancing Prescription Drug Innovation and Adoption

Innovation Adoption and Collective Experimentation∗

I study a game in which individuals gather costly information about an innovation and share their knowledge through social ties. A person’s incentive to experiment varies with her position in the network, and strategic interactions lead to counterintuitive behavior among the most connected players. The structure of the social network and the distribution of initial beliefs jointly determine lon...

The Prevalence of Drug-Drug Interaction and Inappropriate Drug Prescription Among the Elderly in Kashan

Background: Drug-drug Interaction (DDI) among the elderly is one of the major healthcare challenges worldwide. The present study assessed the rates of DDI and inappropriate drug prescription among the elderly in Kashan City, Iran.  Methods: This descriptive-analytical study was designed, conducted, and reported according to the guideline of Strengthening the Reporting of Observational Studies ...

Prescription drug monitoring and drug overdose mortality

BACKGROUND Abuse of prescription drugs, particularly opioid analgesics, has become a major source of injury mortality and morbidity in the United States. To prevent the diversion and misuse of controlled substances, many states have implemented prescription drug monitoring programs (PDMPs). This study assessed the impact of state PDMPs on drug overdose mortality. METHODS We analyzed demograph...

Pharmaceutical arbitrage: balancing access and innovation in international prescription drug markets.

Expensive prescription drugs lie at the heart of two major public health issues: the global AIDS epidemic; and US patients obtaining less expensive drugs from Canada over the internet. Both situations call for reducing financial barriers to innovative drugs while maintaining incentives to promote innovation. For better or for worse, the WTO TRIPS Agreement on intellectual property (IP) is the g...

RFID: Frequency, standards, adoption and innovation